GlassScriptPhysician profile
Jennifer J Schmidt
NPI 1982676540
$4,936.54
in general payments reported to CMS, 2019-2025
36 companies · $981 in 2025
The $981 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $710 · 2020: $364 · 2021: $891 · 2022: $587 · 2023: $541 · 2024: $863 · 2025: $981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,375 · Education: $8.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,375.26 |
| Education | $8.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,299.76 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $446.81 | 2021-2025 | Ubrelvy, Qulipta, Vraylar |
| Lilly USA, LLC | $393.63 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $268.36 | 2019-2024 | Xifaxan |
| Currax Pharmaceuticals LLC | $161.27 | 2020-2024 | Contrave |
| Astrazeneca Pharmaceuticals LP | $160.54 | 2019-2025 | Airsupra, Farxiga |
| Amgen INC. | $142.30 | 2019-2025 | Repatha, Otezla, Krystexxa |
| Abbott Laboratories | $108.88 | 2023-2025 | Eterna, Proclaim, Freestyle Libre 3 |
| Vivus LLC | $96.01 | 2021-2024 | Qsymia |
| Takeda Pharmaceuticals U.S.A., INC. | $91.76 | 2019-2022 | |
| Pfizer INC. | $83.40 | 2021-2025 | |
| Eisai INC. | $69.38 | 2020-2025 | |
| Idorsia Pharmaceuticals US INC | $54.84 | 2022-2024 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $54.17 | 2019-2021 | |
| Medtronic, INC. | $52.31 | 2023-2025 | Intellis Adaptivestim, Inceptiv |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $36.52 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $34.01 | 2021 | |
| Exact Sciences Corporation | $33.27 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.84 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $32.70 | 2024-2025 | Unithroid |
| Dexcom, INC. | $28.89 | 2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $27.17 | 2019-2025 | Gardasil 9, Capvaxive |
| Tactile Systems Technology INC | $26.03 | 2019 | |
| Angiodynamics, INC. | $22.85 | 2019 | |
| Astellas Pharma US INC | $21.76 | 2025 | Veozah |
| Nestle Healthcare Nutrition INC. | $17.42 | 2022 | |
| Boston Scientific Corporation | $17.17 | 2020 | |
| Vanda Pharmaceuticals INC. | $16.78 | 2025 | Hetlioz, Fanapt |
| Amarin Pharma, INC. | $15.23 | 2020 | |
| Insulet Corporation | $15.17 | 2025 | Omnipod |
| Axonics, INC. | $15.07 | 2022 | |
| Arbor Pharmaceuticals, INC. | $12.88 | 2019 | |
| Antares Pharma, INC. | $12.87 | 2019 | |
| Jazz Pharmaceuticals INC. | $12.06 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.57 | 2019 | |
| Medtronic Minimed, INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.